[HTML][HTML] Molecular signature of response to preoperative radiotherapy in locally advanced breast cancer
M Tanić, A Krivokuća, M Čavić, J Mladenović… - Radiation …, 2018 - Springer
Background Radiation therapy is an indispensable part of various treatment modalities for
breast cancer. Specifically, for non-inflammatory locally advanced breast cancer (LABC) …
breast cancer. Specifically, for non-inflammatory locally advanced breast cancer (LABC) …
表观扩散系数直方图预测局部晚期乳腺癌患者新辅助化疗疗效的价值
金观桥， 苏丹柯， 罗殿中， 赖少侣， 罗宁斌， 康巍… - 中华放射学杂志, 2015 - cqvip.com
目的探讨MRADC 直方图预测局部晚期乳腺癌(LABC) 患者新辅助化疗(NACT) 疗效的价值.
方法回顾性分析经病理证实为乳腺浸润性导管癌行NACT 治疗, 且NACT 治疗后行乳腺癌手术的 …
方法回顾性分析经病理证实为乳腺浸润性导管癌行NACT 治疗, 且NACT 治疗后行乳腺癌手术的 …
Reverse abdominoplasty for mastectomy defect closure in advanced breast cancer
K Whalen, L Liu, CJ Rejano, R Mhaskar… - Annals of Plastic …, 2023 - journals.lww.com
Background Breast cancer patients with locally advanced breast cancer who require radical
mastectomy are left with large chest wall defects. This poses a significant reconstructive …
mastectomy are left with large chest wall defects. This poses a significant reconstructive …
Optimal assessment of residual disease after neo‐adjuvant therapy for locally advanced and inflammatory breast cancer—clinical examination, mammography, or …
FC Wright, J Zubovits, S Gardner… - Journal of Surgical …, 2010 - Wiley Online Library
Purpose Accurate assessment of residual disease after neo‐adjuvant chemotherapy (NEC)
for women with locally advanced and inflammatory breast cancer (LABC) is critical for …
for women with locally advanced and inflammatory breast cancer (LABC) is critical for …
[HTML][HTML] Multiparametric monitoring of chemotherapy treatment response in locally advanced breast cancer using quantitative ultrasound and diffuse optical …
Purpose This study evaluated pathological response to neoadjuvant chemotherapy using
quantitative ultrasound (QUS) and diffuse optical spectroscopy imaging (DOSI) biomarkers …
quantitative ultrasound (QUS) and diffuse optical spectroscopy imaging (DOSI) biomarkers …
乳腺癌治疗的现代概念
杨春明 - 中国普外基础与临床杂志, 2008 - cqvip.com
乳腺癌是妇女最常见的恶性疾病, 对其治疗经历了漫长曲折的路程. 从公元前604
年古希腊Leonides 提出外科手术切除, 18 世纪英国Benjimen 采用全乳切除, 1852 年Paneoast …
年古希腊Leonides 提出外科手术切除, 18 世纪英国Benjimen 采用全乳切除, 1852 年Paneoast …
Imaging biomarkers for precision medicine in locally advanced breast cancer
Abstract Guidelines from the American National Comprehensive Cancer Network
recommend neoadjuvant chemotherapy to patients with locally advanced breast cancer …
recommend neoadjuvant chemotherapy to patients with locally advanced breast cancer …
The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer
M Wang, M Zhang, H Chen - Advances in Therapy, 2023 - Springer
Introduction Prognostic prediction based on prognostic stage (PS) with the Oncotype DX
recurrence score (RS) has not been validated in stage III ER+/HER2− breast cancer. This …
recurrence score (RS) has not been validated in stage III ER+/HER2− breast cancer. This …
[PDF][PDF] Neoadjuvant chemotherapy in locally advanced breast cancer
J Iqbal, AA Shafi, BN Alharthi - J Coll Phys Surg Pak, 2014 - jcpsp.pk
Objective: To assess the response to Neoadjuvant Chemotherapy (NAC) in Locally
Advanced Breast Cancer (LABC) in terms of pathological response, overall survival and …
Advanced Breast Cancer (LABC) in terms of pathological response, overall survival and …
How effective is the treatment of locally advanced and metastatic breast cancer in developing centres?: A retrospective review
BACKGROUND: The use of chemotherapy in advanced metastatic breast cancer remains a
subject of controversy. The thought of MicKinnon et al (early 1950s) that the course of breast …
subject of controversy. The thought of MicKinnon et al (early 1950s) that the course of breast …